Agree Realty (ADC) Q1 2025 earnings summary

Executive summary

• Portfolio expanded to 2,422 retail net lease properties across all 50 states, totaling 50.3 million sq. ft., 99.2% leased, and 68.3% of base rent from investment grade tenants as of March 31, 2025.

• Achieved record Q1 2025 investment volume of up to $377 million across three external growth platforms, the largest since Q3 2023.

• Increased 2025 investment guidance to $1.3–$1.5 billion and raised AFFO per share guidance to $4.27–$4.30, implying over 3.5% growth.

• Maintained a focus on necessity-based, e-commerce and recession-resistant retailers, with a diversified portfolio across leading national and super-regional tenants.

• Declared increased monthly dividend of $0.256 per share for April, up 2.4% year-over-year.

Financial highlights

• Rental income rose 13% year-over-year to $169.1 million in Q1 2025; net income attributable to common stockholders increased 5% to $45.1 million.

• Core FFO per share was $1.04, up 3.1% year-over-year; AFFO per share was $1.06, up 3%.

• Declared monthly dividends of $0.253 per share for Q1, increasing to $0.256 in April, with an annualized dividend of over $3.07 per share, up 2.4% year-over-year.

• Dividend payout ratio was 72% of AFFO, with nearly $120 million in free cash flow after dividends, up 15% from last year.

• Operating cash flow increased by $27.5 million year-over-year, driven by portfolio growth.

Outlook and guidance

• 2025 investment guidance raised to $1.3–$1.5 billion and AFFO per share guidance to $4.27–$4.30, representing 3.6% growth at the midpoint.

• Disposition volume guidance maintained at $10–$50 million.

• General and administrative expenses expected at 5.6%–5.9% of adjusted revenue; non-reimbursable real estate expenses at 1.0%–1.5%.

• Guidance includes anticipated treasury stock method dilution of about $0.02 per share, with potential for higher dilution if stock price rises.

• Credit loss guidance for 2025 is 50 basis points, fully loaded for lease expirations and vacancies.